Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Динамика клинико-психологических характеристик больных с синдромом обструктивного апноэ сна и артериальной гипертонией через один месяц использования СИПАП-терапии
Динамика клинико-психологических характеристик больных с синдромом обструктивного апноэ сна и артериальной гипертонией через один месяц использования СИПАП-терапии
Коновалова К.И., Елфимова Е.М., Михайлова О.О. и др. Динамика клинико-психологических характеристик больных с синдромом обструктивного апноэ сна и артериальной гипертонией через один месяц использования СИПАП-терапии. Системные гипертензии. 2017; 14 (3): 65–71. DOI: 10.26442/2075-082X_14.3.65-71
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Цель исследования – определить динамику клинико-психологических характеристик на фоне 1 мес СИПАП-терапии (от англ. Constant Positive Airway Pressure, CPAP) у приверженных и неприверженных лечению больных с синдромом обструктивного апноэ сна (СОАС) и артериальной гипертонией (АГ).
Методы. В исследовании приняли участие 180 больных с СОАС и АГ. При включении в него анализировались антропометрические данные, результаты полисомнографического и кардиореспираторного исследований, опросные шкалы депрессии (Бека), личностной и ситуационной тревожности (шкала Спилбергера), дневной сонливости (шкала Эпворт), качества сна (Питтсбургский опросник) и качества жизни (разработана Всемирной организацией здравоохранения и содержит 100 вопросов). Из 40 больных, находящихся на СИПАП-терапии, приверженными лечению через 1 мес были 30 больных. Критерием приверженности считалось время использования СИПАП-аппарата более 4 ч за ночь, более 5 дней в неделю. В данной статье динамика опросных шкал приводится только для приверженных СИПАП-терапии больных.
Результаты. У пациентов с СОАС и АГ, приверженных СИПАП-терапии, выявлены статически значимое снижение дневной сонливости и депрессии, а также улучшение качества сна и качества жизни в физической сфере уже через 1 мес использования СИПАП-терапии.
Заключение. Даже краткосрочное использование СИПАП-терапии у больных с СОАС и АГ приводит к снижению дневной сонливости и депрессии, улучшению качества сна и качества жизни в физической сфере.
Ключевые слова: синдром обструктивного апноэ сна, артериальная гипертония, СИПАП-терапия, приверженность, сонливость, тревожность, депрессия, качество сна, качество жизни.
Methods. The study included 180 patients with OSA and AH. Upon enrollment, anthropometric data, the results of polysomnography and cardiorespiratory studies, Beck depression scale, Spielberger personal and situational anxiety scale, Epworth daytime sleepiness scale, Pittsburgh sleep quality questionnaire and Quality of Life (WHO QOL-100) questionnaire were analysed. Out of 40 patients undergoing CPAP therapy, 30 patients were adherent to the treatment within a month. The adherence criterion was considered to be the usage of the CPAP device more than 4 hours per night, more than 5 days a week. In this article, the dynamics of the questionnaire scales is given only for those who were adherent to CPAP therapy.
Results. Patients with OSA and AH adherent to CPAP therapy showed a statistically significant reduction in daytime sleepiness and depression, as well as improved quality of sleep and quality of life in the physical domain within 1 month of using CPAP therapy.
Conclusion. Even short-term use of CPAP therapy in patients with OSA and AH leads to a reduction in daytime sleepiness and depression, improved quality of sleep and quality of life in the physical domain.
Key words: obstructive sleep apnea syndrome, arterial hypertension, CPAP therapy, adherence, drowsiness, anxiety, depression, sleep quality, quality of life.
Методы. В исследовании приняли участие 180 больных с СОАС и АГ. При включении в него анализировались антропометрические данные, результаты полисомнографического и кардиореспираторного исследований, опросные шкалы депрессии (Бека), личностной и ситуационной тревожности (шкала Спилбергера), дневной сонливости (шкала Эпворт), качества сна (Питтсбургский опросник) и качества жизни (разработана Всемирной организацией здравоохранения и содержит 100 вопросов). Из 40 больных, находящихся на СИПАП-терапии, приверженными лечению через 1 мес были 30 больных. Критерием приверженности считалось время использования СИПАП-аппарата более 4 ч за ночь, более 5 дней в неделю. В данной статье динамика опросных шкал приводится только для приверженных СИПАП-терапии больных.
Результаты. У пациентов с СОАС и АГ, приверженных СИПАП-терапии, выявлены статически значимое снижение дневной сонливости и депрессии, а также улучшение качества сна и качества жизни в физической сфере уже через 1 мес использования СИПАП-терапии.
Заключение. Даже краткосрочное использование СИПАП-терапии у больных с СОАС и АГ приводит к снижению дневной сонливости и депрессии, улучшению качества сна и качества жизни в физической сфере.
Ключевые слова: синдром обструктивного апноэ сна, артериальная гипертония, СИПАП-терапия, приверженность, сонливость, тревожность, депрессия, качество сна, качество жизни.
________________________________________________
Methods. The study included 180 patients with OSA and AH. Upon enrollment, anthropometric data, the results of polysomnography and cardiorespiratory studies, Beck depression scale, Spielberger personal and situational anxiety scale, Epworth daytime sleepiness scale, Pittsburgh sleep quality questionnaire and Quality of Life (WHO QOL-100) questionnaire were analysed. Out of 40 patients undergoing CPAP therapy, 30 patients were adherent to the treatment within a month. The adherence criterion was considered to be the usage of the CPAP device more than 4 hours per night, more than 5 days a week. In this article, the dynamics of the questionnaire scales is given only for those who were adherent to CPAP therapy.
Results. Patients with OSA and AH adherent to CPAP therapy showed a statistically significant reduction in daytime sleepiness and depression, as well as improved quality of sleep and quality of life in the physical domain within 1 month of using CPAP therapy.
Conclusion. Even short-term use of CPAP therapy in patients with OSA and AH leads to a reduction in daytime sleepiness and depression, improved quality of sleep and quality of life in the physical domain.
Key words: obstructive sleep apnea syndrome, arterial hypertension, CPAP therapy, adherence, drowsiness, anxiety, depression, sleep quality, quality of life.
Полный текст
Список литературы
1. Kapur VK, Auckley DH, Chowdhuri S et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13 (3).
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14.
3. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6 (2): 131–7.
4. Ravesloot MJ, van Maanen JP, Hilgevoord AA et al. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012; 269 (7): 1865–71.
5. Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4: 411–33.
6. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res 2011; 190: 53–68.
7. Литвин А.Ю., Михайлова О.О., Елфимова Е.М. и др. Синдром обструктивного апноэ сна и артериальная гипертония: двунаправленная взаимосвязь. Consilium Medicum. 2015; 17 (10): 34–9. / Litvin A.Yu., Mikhailova O.O., Elfimova E.M. et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2015; 17 (10): 34–9. [in Russian]
8. Mooe T, Rabben T, Wiklund U et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109 (3): 659–63.
9. Olson LJ, Somers VK. Sleep apnea: implications for heart failure. Curr Heart Fail Rep 2007; 4: 63–9.
10. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Фомичева О.А. Фибрилляция предсердий и длительные ночные «остановки» сердца у больного с синдромом обструктивного апноэ во сне. Успешная коррекция нарушений при применении СИПАП-терапии. Терапевт. aрхив. 2016; 9: 84–9. / Bajrambekov Je.Sh., Pevzner A.V., Litvin A.Ju., Fomicheva O.A. Fibrilljacija predserdij i dlitel'nye nochnye «ostanovki» serdca u bol'nogo s sindromom obstruktivnogo apnoje vo sne. Uspeshnaja korrekcija narushenij pri primenenii SIPAP-terapii. Terapevt. arhiv. 2016; 9: 84–9. [in Russian]
11. Artz M, Young T, Finn L et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447–51.
12. Reichmuth KJ, Austin D, Skatrud J, Young T. Association of sleep apnea and Type II diabetes. Am J Respir Crit Care Med 2005; 172: 1590–5.
13. Girardin J-L, Clinton D Brown, Zizi F et al. Cardiovascular disease risk reduction with sleep apnea treatment. Expert Rev Cardiovasc Ther 2010; 8 (7): 995–1005.
14. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL, 2005.
15. Weaver TE, Grunstein RR. Adherence to Continuous Positive Airway Pressure Therapy. Proc Am Thorac Soc 2008; 5 (2): 173–8.
16. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002; 121: 430–5.
17. McArdle N, Devereux G, Heindarnejad H et al. Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome. Am J Respir Crit Care Med 1999; 159: 1108–14.
18. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103: 1675–80.
19. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: An objective evaluation of patient compliance. Am J Respir Critical Care Med 1994; 149: 149–54.
20. Peker Y, Glantz H, Eulenburg C et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. Am J Respir Crit Care Med 2016; 194 (5): 613–20.
21. Antic NA, Heeley E, Anderson CS et al. The Sleep Apnea cardioVascular Endpoints (SAVE) trial: rationale, ethics, design, and progress. Sleep 2015; 38: 1247–57.
22. Effects of CPAP on «vascular» risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 2013; 9: 229–35. DOI: 10.2147/VHRM.S40231.
23. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
24. Sanchez AI, Buela-Casal G, Bermudez MP, Casas-Maldonado F. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci 2001; 55: 641–6.
25. Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology 2013; 18 (1): 61–70.
26. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
27. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
28. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149–54.
29. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
30. Johns M. A new method for measuring daytime sleepiness: the ESS. Sleep 1991; 14: 540–5.
31. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.
32. Engleman HM, Martin SE, Kingshott RN et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53: 341–5.
33. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 1989; 50: 348–51. [PubMed].
34. Guilleminault C, Eldridge FL, Tilkian A et al. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med 1977; 137: 296–300.
35. Kawahara S, Akashiba T, Akahoshi T et al. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 2005; 44: 422–7.
36. Sharafkhaneh A, Giray N, Richardson P et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28 (11): 1405–11.
37. Loredo JS, Ancoli-Israel S, Kim E-J et al. Dimsdale. Effect of Continuous Positive Airway Pressure Versus Supplemental Oxygen on Sleep Quality in Obstructive Sleep Apnea: A Placebo-CPAP-Controlled Study. Sleep 2006; 29 (4).
38. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116: 1545–9.
39. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001; 164: 1459–63.
40. Wang Y, He P, Teng B et al. Effect of CPAP therapy on sleep quality and quality of life in patients with moderate or severe OSAHS. Rev Med Chir Soc Med Nat Iasi 2010; 114 (2): 367–71.
41. Bennett LS, Barbour C, Langford B et al. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytine sleepiness, and effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med 1999; 159 (6): 1884–90.
42. Pichel F, Zamarrón C, Magán F et al. Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment. Respir Med 2004; 98 (10): 968–76.
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14.
3. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6 (2): 131–7.
4. Ravesloot MJ, van Maanen JP, Hilgevoord AA et al. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012; 269 (7): 1865–71.
5. Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4: 411–33.
6. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res 2011; 190: 53–68.
7. Litvin A.Yu., Mikhailova O.O., Elfimova E.M. et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2015; 17 (10): 34–9. [in Russian]
8. Mooe T, Rabben T, Wiklund U et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109 (3): 659–63.
9. Olson LJ, Somers VK. Sleep apnea: implications for heart failure. Curr Heart Fail Rep 2007; 4: 63–9.
10. Bajrambekov Je.Sh., Pevzner A.V., Litvin A.Ju., Fomicheva O.A. Fibrilljacija predserdij i dlitel'nye nochnye «ostanovki» serdca u bol'nogo s sindromom obstruktivnogo apnoje vo sne. Uspeshnaja korrekcija narushenij pri primenenii SIPAP-terapii. Terapevt. arhiv. 2016; 9: 84–9. [in Russian]
11. Artz M, Young T, Finn L et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447–51.
12. Reichmuth KJ, Austin D, Skatrud J, Young T. Association of sleep apnea and Type II diabetes. Am J Respir Crit Care Med 2005; 172: 1590–5.
13. Girardin J-L, Clinton D Brown, Zizi F et al. Cardiovascular disease risk reduction with sleep apnea treatment. Expert Rev Cardiovasc Ther 2010; 8 (7): 995–1005.
14. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL, 2005.
15. Weaver TE, Grunstein RR. Adherence to Continuous Positive Airway Pressure Therapy. Proc Am Thorac Soc 2008; 5 (2): 173–8.
16. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002; 121: 430–5.
17. McArdle N, Devereux G, Heindarnejad H et al. Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome. Am J Respir Crit Care Med 1999; 159: 1108–14.
18. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103: 1675–80.
19. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: An objective evaluation of patient compliance. Am J Respir Critical Care Med 1994; 149: 149–54.
20. Peker Y, Glantz H, Eulenburg C et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. Am J Respir Crit Care Med 2016; 194 (5): 613–20.
21. Antic NA, Heeley E, Anderson CS et al. The Sleep Apnea cardioVascular Endpoints (SAVE) trial: rationale, ethics, design, and progress. Sleep 2015; 38: 1247–57.
22. Effects of CPAP on «vascular» risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 2013; 9: 229–35. DOI: 10.2147/VHRM.S40231.
23. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
24. Sanchez AI, Buela-Casal G, Bermudez MP, Casas-Maldonado F. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci 2001; 55: 641–6.
25. Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology 2013; 18 (1): 61–70.
26. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
27. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
28. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149–54.
29. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
30. Johns M. A new method for measuring daytime sleepiness: the ESS. Sleep 1991; 14: 540–5.
31. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.
32. Engleman HM, Martin SE, Kingshott RN et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53: 341–5.
33. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 1989; 50: 348–51. [PubMed].
34. Guilleminault C, Eldridge FL, Tilkian A et al. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med 1977; 137: 296–300.
35. Kawahara S, Akashiba T, Akahoshi T et al. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 2005; 44: 422–7.
36. Sharafkhaneh A, Giray N, Richardson P et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28 (11): 1405–11.
37. Loredo JS, Ancoli-Israel S, Kim E-J et al. Dimsdale. Effect of Continuous Positive Airway Pressure Versus Supplemental Oxygen on Sleep Quality in Obstructive Sleep Apnea: A Placebo-CPAP-Controlled Study. Sleep 2006; 29 (4).
38. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116: 1545–9.
39. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001; 164: 1459–63.
40. Wang Y, He P, Teng B et al. Effect of CPAP therapy on sleep quality and quality of life in patients with moderate or severe OSAHS. Rev Med Chir Soc Med Nat Iasi 2010; 114 (2): 367–71.
41. Bennett LS, Barbour C, Langford B et al. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytine sleepiness, and effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med 1999; 159 (6): 1884–90.
42. Pichel F, Zamarrón C, Magán F et al. Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment. Respir Med 2004; 98 (10): 968–76.
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14.
3. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6 (2): 131–7.
4. Ravesloot MJ, van Maanen JP, Hilgevoord AA et al. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012; 269 (7): 1865–71.
5. Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4: 411–33.
6. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res 2011; 190: 53–68.
7. Литвин А.Ю., Михайлова О.О., Елфимова Е.М. и др. Синдром обструктивного апноэ сна и артериальная гипертония: двунаправленная взаимосвязь. Consilium Medicum. 2015; 17 (10): 34–9. / Litvin A.Yu., Mikhailova O.O., Elfimova E.M. et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2015; 17 (10): 34–9. [in Russian]
8. Mooe T, Rabben T, Wiklund U et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109 (3): 659–63.
9. Olson LJ, Somers VK. Sleep apnea: implications for heart failure. Curr Heart Fail Rep 2007; 4: 63–9.
10. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Фомичева О.А. Фибрилляция предсердий и длительные ночные «остановки» сердца у больного с синдромом обструктивного апноэ во сне. Успешная коррекция нарушений при применении СИПАП-терапии. Терапевт. aрхив. 2016; 9: 84–9. / Bajrambekov Je.Sh., Pevzner A.V., Litvin A.Ju., Fomicheva O.A. Fibrilljacija predserdij i dlitel'nye nochnye «ostanovki» serdca u bol'nogo s sindromom obstruktivnogo apnoje vo sne. Uspeshnaja korrekcija narushenij pri primenenii SIPAP-terapii. Terapevt. arhiv. 2016; 9: 84–9. [in Russian]
11. Artz M, Young T, Finn L et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447–51.
12. Reichmuth KJ, Austin D, Skatrud J, Young T. Association of sleep apnea and Type II diabetes. Am J Respir Crit Care Med 2005; 172: 1590–5.
13. Girardin J-L, Clinton D Brown, Zizi F et al. Cardiovascular disease risk reduction with sleep apnea treatment. Expert Rev Cardiovasc Ther 2010; 8 (7): 995–1005.
14. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL, 2005.
15. Weaver TE, Grunstein RR. Adherence to Continuous Positive Airway Pressure Therapy. Proc Am Thorac Soc 2008; 5 (2): 173–8.
16. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002; 121: 430–5.
17. McArdle N, Devereux G, Heindarnejad H et al. Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome. Am J Respir Crit Care Med 1999; 159: 1108–14.
18. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103: 1675–80.
19. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: An objective evaluation of patient compliance. Am J Respir Critical Care Med 1994; 149: 149–54.
20. Peker Y, Glantz H, Eulenburg C et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. Am J Respir Crit Care Med 2016; 194 (5): 613–20.
21. Antic NA, Heeley E, Anderson CS et al. The Sleep Apnea cardioVascular Endpoints (SAVE) trial: rationale, ethics, design, and progress. Sleep 2015; 38: 1247–57.
22. Effects of CPAP on «vascular» risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 2013; 9: 229–35. DOI: 10.2147/VHRM.S40231.
23. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
24. Sanchez AI, Buela-Casal G, Bermudez MP, Casas-Maldonado F. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci 2001; 55: 641–6.
25. Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology 2013; 18 (1): 61–70.
26. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
27. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
28. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149–54.
29. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
30. Johns M. A new method for measuring daytime sleepiness: the ESS. Sleep 1991; 14: 540–5.
31. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.
32. Engleman HM, Martin SE, Kingshott RN et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53: 341–5.
33. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 1989; 50: 348–51. [PubMed].
34. Guilleminault C, Eldridge FL, Tilkian A et al. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med 1977; 137: 296–300.
35. Kawahara S, Akashiba T, Akahoshi T et al. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 2005; 44: 422–7.
36. Sharafkhaneh A, Giray N, Richardson P et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28 (11): 1405–11.
37. Loredo JS, Ancoli-Israel S, Kim E-J et al. Dimsdale. Effect of Continuous Positive Airway Pressure Versus Supplemental Oxygen on Sleep Quality in Obstructive Sleep Apnea: A Placebo-CPAP-Controlled Study. Sleep 2006; 29 (4).
38. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116: 1545–9.
39. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001; 164: 1459–63.
40. Wang Y, He P, Teng B et al. Effect of CPAP therapy on sleep quality and quality of life in patients with moderate or severe OSAHS. Rev Med Chir Soc Med Nat Iasi 2010; 114 (2): 367–71.
41. Bennett LS, Barbour C, Langford B et al. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytine sleepiness, and effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med 1999; 159 (6): 1884–90.
42. Pichel F, Zamarrón C, Magán F et al. Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment. Respir Med 2004; 98 (10): 968–76.
________________________________________________
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14.
3. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6 (2): 131–7.
4. Ravesloot MJ, van Maanen JP, Hilgevoord AA et al. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012; 269 (7): 1865–71.
5. Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4: 411–33.
6. Jackson ML, Howard ME, Barnes M. Cognition and daytime functioning in sleep-related breathing disorders. Prog Brain Res 2011; 190: 53–68.
7. Litvin A.Yu., Mikhailova O.O., Elfimova E.M. et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2015; 17 (10): 34–9. [in Russian]
8. Mooe T, Rabben T, Wiklund U et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109 (3): 659–63.
9. Olson LJ, Somers VK. Sleep apnea: implications for heart failure. Curr Heart Fail Rep 2007; 4: 63–9.
10. Bajrambekov Je.Sh., Pevzner A.V., Litvin A.Ju., Fomicheva O.A. Fibrilljacija predserdij i dlitel'nye nochnye «ostanovki» serdca u bol'nogo s sindromom obstruktivnogo apnoje vo sne. Uspeshnaja korrekcija narushenij pri primenenii SIPAP-terapii. Terapevt. arhiv. 2016; 9: 84–9. [in Russian]
11. Artz M, Young T, Finn L et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447–51.
12. Reichmuth KJ, Austin D, Skatrud J, Young T. Association of sleep apnea and Type II diabetes. Am J Respir Crit Care Med 2005; 172: 1590–5.
13. Girardin J-L, Clinton D Brown, Zizi F et al. Cardiovascular disease risk reduction with sleep apnea treatment. Expert Rev Cardiovasc Ther 2010; 8 (7): 995–1005.
14. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL, 2005.
15. Weaver TE, Grunstein RR. Adherence to Continuous Positive Airway Pressure Therapy. Proc Am Thorac Soc 2008; 5 (2): 173–8.
16. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002; 121: 430–5.
17. McArdle N, Devereux G, Heindarnejad H et al. Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome. Am J Respir Crit Care Med 1999; 159: 1108–14.
18. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103: 1675–80.
19. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: An objective evaluation of patient compliance. Am J Respir Critical Care Med 1994; 149: 149–54.
20. Peker Y, Glantz H, Eulenburg C et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. Am J Respir Crit Care Med 2016; 194 (5): 613–20.
21. Antic NA, Heeley E, Anderson CS et al. The Sleep Apnea cardioVascular Endpoints (SAVE) trial: rationale, ethics, design, and progress. Sleep 2015; 38: 1247–57.
22. Effects of CPAP on «vascular» risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 2013; 9: 229–35. DOI: 10.2147/VHRM.S40231.
23. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
24. Sanchez AI, Buela-Casal G, Bermudez MP, Casas-Maldonado F. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci 2001; 55: 641–6.
25. Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology 2013; 18 (1): 61–70.
26. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
27. Engleman HM, Kingshott RN, Wraith PK et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461–7.
28. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149–54.
29. Engleman HM, Martin SE, Deary IJ et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572–5.
30. Johns M. A new method for measuring daytime sleepiness: the ESS. Sleep 1991; 14: 540–5.
31. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.
32. Engleman HM, Martin SE, Kingshott RN et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53: 341–5.
33. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 1989; 50: 348–51. [PubMed].
34. Guilleminault C, Eldridge FL, Tilkian A et al. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med 1977; 137: 296–300.
35. Kawahara S, Akashiba T, Akahoshi T et al. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 2005; 44: 422–7.
36. Sharafkhaneh A, Giray N, Richardson P et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28 (11): 1405–11.
37. Loredo JS, Ancoli-Israel S, Kim E-J et al. Dimsdale. Effect of Continuous Positive Airway Pressure Versus Supplemental Oxygen on Sleep Quality in Obstructive Sleep Apnea: A Placebo-CPAP-Controlled Study. Sleep 2006; 29 (4).
38. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116: 1545–9.
39. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001; 164: 1459–63.
40. Wang Y, He P, Teng B et al. Effect of CPAP therapy on sleep quality and quality of life in patients with moderate or severe OSAHS. Rev Med Chir Soc Med Nat Iasi 2010; 114 (2): 367–71.
41. Bennett LS, Barbour C, Langford B et al. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytine sleepiness, and effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med 1999; 159 (6): 1884–90.
42. Pichel F, Zamarrón C, Magán F et al. Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment. Respir Med 2004; 98 (10): 968–76.
Авторы
К.И.Коновалова, Е.М.Елфимова, О.О.Михайлова, В.И.Федорова, А.Ю.Литвин*
Институт клинической кардиологии им. А.Л.Мясникова ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России. 121552, Россия, Москва, ул. 3-я Черепковская, д. 15а
*alelitvin@yandex.ru
A.L.Myasnikov Institute of Clinical Cardiology National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation. 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
*alelitvin@yandex.ru
Институт клинической кардиологии им. А.Л.Мясникова ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России. 121552, Россия, Москва, ул. 3-я Черепковская, д. 15а
*alelitvin@yandex.ru
________________________________________________
A.L.Myasnikov Institute of Clinical Cardiology National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation. 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
*alelitvin@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.